RxDoctor Payments Data

Matthew Hill, PA

Physician Assistant · Logan, UTNPI 1386248292

Payments from drug & device makers

$423in general payments, 2019–2025

Across 15 payments — averaging $28.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$155
  • AbbVie$107
  • Boehringer Ingelheim$40
  • Redhill Biopharma Inc.$33
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$15
  • Bayer$15
  • plus $56 from 4 others

What the payments were for

  • Food & beverage$423100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$423 in reported general payments places this provider in the 55th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$61,581
Medicare patients
170
Services billed
1,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban174$151,449
TrulicityDulaglutide123$150,848
JardianceEmpagliflozin103$126,294
MounjaroTirzepatide114$125,449
XareltoRivaroxaban80$96,226
MyrbetriqMirabegron31$22,006
Xtampza ErOxycodone Myristate26$16,484
Lantus SolostarInsulin Glargine,hum.Rec.Anlog78$15,655
FarxigaDapagliflozin Propanediol15$13,768
OzempicSemaglutide14$13,704
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$10,856
Aimovig AutoinjectorErenumab-Aooe12$9,353
EntrestoSacubitril/Valsartan12$8,769
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$8,713
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,990

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$15$276,297237 claims
Boehringer IngelheimJardiance$40$126,294103 claims
AstraZenecaFarxiga, Symbicort$155$19,20138 claims
NovartisEntresto$14$8,76912 claims
GSKTrelegy Ellipta$14$7,99012 claims
AbbVieSynthroid$107$2,74028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Logan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →